원료의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 7.3%로 3,261억 3,000만 달러로 성장할 것으로 보입니다. 예측기간의 성장은 헬스케어 지출 증가, 희소질환에 대한 주목 증가, 바이오시밀러 시장의 확대, 그린케미스트리의 진보, 지속적인 제조에 대한 주력, 혁신에 대한 규제당국의 지원, 임상시험의 세계화, 지속가능하고 윤리적인 실천에 대한 주력 등에 기인한다고 생각됩니다. 예측 기간의 주요 개발 동향으로는 의약품 개발의 디지털화, 첨단 제조 기술에 대한 투자, 희소질환·희소질환용 의약품용 원약, 품질에 관한 규제 당국의 감시, 원약의 시리얼화와 추적 가능성, 바이오의약품과 바이오테크놀러지 제품 등을 들 수 있습니다.
만성 질환의 만연 확대는 의약품 활성 성분(API) 시장의 성장 촉진요인이 될 것으로 예상됩니다. 만성 질환은 3개월 이상 지속되며, 종종 시간이 지남에 따라 악화되는 것으로 암, 심장병, 뇌졸중, 당뇨병, 관절염 등의 질환을 포함합니다. API는 종양학, 심장병학, 신경학, 정형외과학 등 다양한 질병에 대응하는 고품질 의약품에 필수적입니다. 예를 들어, 국제 당뇨병 연합은 당뇨병 환자가 2030년까지 5억 7,800만 명, 2045년까지 7억 명으로 크게 증가했으며, 당뇨병 관련 사망의 거의 절반이 60세 미만 성인에서 발생하여 사망 원인의 톱 10에 들어갈 것으로 예측했습니다. 따라서 만성질환의 이환율 증가는 API 시장의 성장을 가속할 것으로 예상됩니다.
연구개발(R&D) 투자 증가는 향후 수년간 원료의약품(API) 시장의 성장을 가속할 것으로 예측됩니다. R&D 투자는 새로운 지식 창출, 혁신적인 제품, 서비스, 프로세스 개발, 기존 제품의 강화를 목표로 하는 활동에 자금, 인적, 기술적 자원을 배분하는 것을 포함합니다. 연구 개발은 혁신을 촉진하고 제품의 품질을 향상시키고 제약 업계의 진보를 추진하기 위해 원료의 진보에 필수적입니다. 바이오의약품기업과 정부기관은 치료성적 향상과 언메트 메디컬 니즈에 대한 대응을 목표로 혁신적인 원약 및 제제를 창출하기 위해 연구개발에 투자하고 있습니다. 예를 들어, 캐나다 정부 기관인 캐나다 통계국은 2024년 9월, 캐나다 기업이 2022년 사내 연구개발에 소비한 금액은 과거 최고의 304억 달러에 달하고, 2021년부터 9.4% 증가했다고 보고했습니다. 이와 같이 R&D 투자의 확대는 원료의약품 시장의 확대를 촉진하는 중요한 요인이 되고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계의 원료의약품 시장의 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인, 성장 억제요인)
- 최종 이용 산업의 분석
- 세계의 원료의약품 시장 : 성장률 분석
- 세계의 원료의약품 시장 실적 : 규모와 성장(2019-2024년), 10억 달러
- 세계의 원료의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년), 10억 달러
- 세계의 원료의약품 총 주소 가능 시장(TAM)
제6장 시장 세분화
- 세계의 원료의약품 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 혁신적 API(원료의약품)
- 제네릭 API(원료의약품)
- 세계의 원료의약품 시장 : 제조업체별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 캡티브 제조업체
- 판매자 제조업체
- 세계의 원료의약품 시장 : 약유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 처방약
- 일반의약품
- 세계의 원료의약품 시장 : 치료 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 전염성 질환
- 종양학
- 당뇨병
- 심혈관 질환
- 통증 관리
- 호흡기 질환
- 기타
- 세계의 원료의약품 시장 : 혁신적 API의 서브 세분화 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 생물학적 제제
- 신규화학물질(NCE)
- 표적 치료제
- 세계의 원료의약품 시장 : 제네릭 API의 서브 세분화 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 특허 외 의약품
- 바이오시밀러
- 일반의약품(OTC)
제7장 지역별·국가별 분석
- 세계의 원료의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
- 세계의 원료의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년), 10억 달러
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
- 원료의약품 시장 : 경쟁 구도
- 원료의약품 시장 : 기업 프로파일
- Albemarle Corporation 개요, 제품 및 서비스, 전략 및 재무 분석
- Aurobindo Pharma Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- Dr. Reddy's Laboratories Limited 개요, 제품 및 서비스, 전략 및 재무 분석
- AbbVie Inc. 개요, 제품 및 서비스, 전략 및 재무 분석
- Teva Pharmaceutical Industries Limited 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
- Cipla Limited
- Boehringer Ingelheim International GmbH
- Merck KGaA
- Sun Pharmaceutical Industries Limited
- Bristol-Myers Squibb Company
- Mylan Pharmaceuticals ULC
- BASF SE
- Lupin Limited
- Johnson & Johnson Services Inc.
- F. Hoffmann-La Roche AG
- Pfizer Inc.
- Novartis International AG
- Sanofi SA
- Viatris Inc.
- Cadila Pharmaceuticals Limited
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
- 원료의약품 시장(2029년) : 새로운 기회를 제공하는 국가
- 원료의약품 시장(2029년) : 새로운 기회를 제공하는 부문
- 원료의약품 시장(2029년) : 성장 전략
제36장 부록
KTH
An active pharmaceutical ingredient (API) is a crucial component or substance utilized in the production of a finished pharmaceutical product (FPP). It is specifically designed to exhibit pharmacological action or directly impact the treatment, mitigation, cure, or prevention of diseases. APIs also play a role in restoring, correcting, or modifying human physiological processes.
There are two main types of active pharmaceutical ingredients such as innovative APIs and generic APIs. Innovative APIs are associated with drugs containing active ingredients or combinations that have not been previously approved. These are often used to offer unique treatments for conditions lacking effective existing remedies. Manufacturers of APIs can be categorized as captive manufacturers and merchant manufacturers. The synthesis types of APIs include synthetic APIs and biotech APIs. These ingredients find applications in both prescription and over-the-counter drugs, targeting therapeutic areas such as communicable diseases, oncology, diabetes, cardiovascular disease, pain management, respiratory diseases, and others.
The active pharmaceutical ingredients market research report is one of a series of new reports from The Business Research Company that provides active pharmaceutical ingredients market statistics, including active pharmaceutical ingredients industry global market size, regional shares, competitors with an active pharmaceutical ingredients market share, detailed active pharmaceutical ingredients market segments, market trends and opportunities, and any further data you may need to thrive in the active pharmaceutical ingredients industry. These active pharmaceutical ingredients market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The active pharmaceutical ingredients market size has grown strongly in recent years. It will grow from $230.83 billion in 2024 to $246.41 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to advancements in drug development, expansion of generic drug market, globalization of pharmaceutical manufacturing, regulatory initiatives for drug safety, rise in contract manufacturing organizations (CMOs), focus on precision medicine, emergence of biopharmaceuticals, global pandemics and health threats.
The active pharmaceutical ingredients market size is expected to see strong growth in the next few years. It will grow to $326.13 billion in 2029 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to increasing healthcare expenditure, increasing focus on rare diseases, expansion of biosimilars market, advancements in green chemistry, focus on continuous manufacturing, regulatory support for innovation, globalization of clinical trials, focus on sustainable and ethical practices. Major trends in the forecast period include digitalization of drug development, investment in advanced manufacturing technologies, APIs for rare diseases and orphan drugs, regulatory scrutiny on quality, API serialization and traceability, biopharmaceuticals and biotechnology products.
The expanding prevalence of chronic diseases is anticipated to be a driving factor for the growth of the active pharmaceutical ingredients (API) market. Chronic diseases, persisting for three months or more and often worsening over time, encompass conditions like cancer, heart disease, stroke, diabetes, and arthritis. APIs are integral to high-quality medications addressing various illnesses such as oncology, cardiology, neurology, and orthopedics. For instance, the International Diabetes Federation predicts a significant rise in diabetes cases to 578 million by 2030 and 700 million by 2045, with nearly half of diabetes-related deaths occurring in adults under 60, making it a top 10 cause of mortality. Hence, the escalating incidence of chronic diseases is expected to propel growth in the API market.
The rising investment in research and development (R&D) is projected to drive the growth of the active pharmaceutical ingredients (APIs) market in the coming years. Investment in R&D involves allocating resources-financial, human, and technological-toward activities aimed at generating new knowledge, developing innovative products, services, or processes, and enhancing existing offerings. R&D is vital for the advancement of APIs, as it fosters innovation, improves product quality, and propels progress in the pharmaceutical industry. Biopharmaceutical companies and government agencies invest in R&D to create innovative APIs and formulations that aim to enhance treatment outcomes and address unmet medical needs. For example, in September 2024, Statistics Canada, a Canadian government agency, reported that Canadian businesses spent a record $30.4 billion on in-house R&D in 2022, marking a 9.4% increase from 2021. Thus, the growing investment in R&D is a key factor driving the expansion of the active pharmaceutical ingredients market.
Technological advancements represent a pivotal trend gaining traction within the active pharmaceutical ingredients market. Leading market players are directing efforts toward implementing innovative technologies and methods for optimized API production. Techniques like continuous flow chemistry, advancements in lyophilization, powder handling, and process control are focal points for major companies aiming to maintain their market standing. A notable example involves the collaboration between NovAliX, ALYSOPHIL SAS, De Dietrich Process Systems, and Bruker in May 2022. This partnership introduced a groundbreaking approach to API production through the PIPAc (Production Intelligente de Principes Actifs) project. PIPAc aims to revolutionize API manufacturing by minimizing complex supply chains in pharmaceutical production and developing rapid-response mobile API production units for global deployment. Leveraging cutting-edge synthesis, continuous flow chemistry, in-flow analysis, and artificial intelligence, PIPAc seeks to create next-generation, autonomous, and optimized units.
Leading firms within the active pharmaceutical ingredients (API) sector are concentrating on the introduction of pioneering solutions, like Capsugel Enprotect, aimed at driving their market revenues. An innovative API solution represents an advanced pharmaceutical compound serving as the biologically active element in drug products. For example, in November 2022, Lonza Group AG unveiled Capsugel Enprotect, a groundbreaking capsule solution designed to transport acid-sensitive active pharmaceutical ingredients to the intestine. This coating-free capsule, a first of its kind, expedites drug development timelines by simplifying the manufacturing process, as it remains intact during stomach transit and releases its contents solely in the intestine. This innovative delivery method is tailored for use with small molecules, proteins, peptides, RNA-based medicines, and even aids in delivering living biotherapeutic products-an innovative class of medical interventions.
In September 2023, Barentz BV, a Netherlands-based company specializing in the distribution of ingredients and specialty chemicals, acquired Unijaya for an undisclosed amount. This acquisition is intended to strengthen Barentz BV's market position, expand its product offerings, and enhance its service capabilities. Unijaya is an Indonesian manufacturing company that plays a significant role in the distribution of Active Pharmaceutical Ingredients.
Major companies operating in the active pharmaceutical ingredients market are Albemarle Corporation, Aurobindo Pharma Limited, Dr. Reddy's Laboratories Limited, AbbVie Inc., Teva Pharmaceutical Industries Limited, Cipla Limited, Boehringer Ingelheim International GmbH, Merck KGaA, Sun Pharmaceutical Industries Limited, Bristol-Myers Squibb Company, Mylan Pharmaceuticals ULC, BASF SE, Lupin Limited, Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Pfizer Inc., Novartis International AG, Sanofi S.A, Viatris Inc., Cadila Pharmaceuticals Limited, Amneal Pharmaceuticals Inc., Apotex Inc., Lonza Group AG, HPM Chemicals and Fertilizers Ltd., GlaxoSmithKline PLC, Godrej Consumer Products, Daiichi Sankyo Inc., Catalent Inc.
North America was the largest region in the active pharmaceutical ingredients market share in 2024. The regions covered in the active pharmaceutical ingredients market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the active pharmaceutical ingredients market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The active pharmaceutical ingredient market consists of sales of active pharmaceutical ingredients that are used in final pharmaceutical products such as drug products (tablet, pill, cream, or injectable) to deliver a desired effect. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Active Pharmaceutical Ingredients Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on active pharmaceutical ingredients market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for active pharmaceutical ingredients ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The active pharmaceutical ingredients market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Type: Innovative APIs (Active Pharmaceutical Ingredient); Generic APIs (Active Pharmaceutical Ingredient)
- 2) By Manufacturer: Captive Manufacturers; Merchant Manufacturers
- 3) By Type Of Drug: Prescription Drugs; Over-The-Counter Drugs
- 4) By Therapeutic Application: Communicable Diseases; Oncology; Diabetes; Cardiovascular Disease; Pain Management; Respiratory Diseases; Other Therapeutic Applications
- Subsegments:
- 1) By Innovative APIs: Biologics; Novel Chemical Entities (NCEs); Targeted Therapies
- 2) By Generic APIs: Off-Patent Pharmaceuticals; Biosimilars; Over-The-Counter (OTC) Generic Drugs
- Companies Mentioned: Albemarle Corporation; Aurobindo Pharma Limited; Dr. Reddy's Laboratories Limited; AbbVie Inc.; Teva Pharmaceutical Industries Limited
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Active Pharmaceutical Ingredients Market Characteristics
3. Active Pharmaceutical Ingredients Market Trends And Strategies
4. Active Pharmaceutical Ingredients Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Active Pharmaceutical Ingredients Growth Analysis And Strategic Analysis Framework
- 5.1. Global Active Pharmaceutical Ingredients PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Active Pharmaceutical Ingredients Market Growth Rate Analysis
- 5.4. Global Active Pharmaceutical Ingredients Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Active Pharmaceutical Ingredients Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Active Pharmaceutical Ingredients Total Addressable Market (TAM)
6. Active Pharmaceutical Ingredients Market Segmentation
- 6.1. Global Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Innovative APIs (Active Pharmaceutical Ingredient)
- Generic APIs (Active Pharmaceutical Ingredient)
- 6.2. Global Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Captive Manufacturers
- Merchant Manufacturers
- 6.3. Global Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prescription Drugs
- Over-The-Counter Drugs
- 6.4. Global Active Pharmaceutical Ingredients Market, Segmentation By Therapeutic Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Communicable Diseases
- Oncology
- Diabetes
- Cardiovascular Disease
- Pain Management
- Respiratory Diseases
- Other Therapeutic Applications
- 6.5. Global Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Innovative APIs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Biologics
- Novel Chemical Entities (NCEs)
- Targeted Therapies
- 6.6. Global Active Pharmaceutical Ingredients Market, Sub-Segmentation Of Generic APIs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Off-Patent Pharmaceuticals
- Biosimilars
- Over-The-Counter (OTC) Generic Drugs
7. Active Pharmaceutical Ingredients Market Regional And Country Analysis
- 7.1. Global Active Pharmaceutical Ingredients Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Active Pharmaceutical Ingredients Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Active Pharmaceutical Ingredients Market
- 8.1. Asia-Pacific Active Pharmaceutical Ingredients Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Active Pharmaceutical Ingredients Market
- 9.1. China Active Pharmaceutical Ingredients Market Overview
- 9.2. China Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Active Pharmaceutical Ingredients Market
- 10.1. India Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Active Pharmaceutical Ingredients Market
- 11.1. Japan Active Pharmaceutical Ingredients Market Overview
- 11.2. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Active Pharmaceutical Ingredients Market
- 12.1. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Active Pharmaceutical Ingredients Market
- 13.1. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Active Pharmaceutical Ingredients Market
- 14.1. South Korea Active Pharmaceutical Ingredients Market Overview
- 14.2. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Active Pharmaceutical Ingredients Market
- 15.1. Western Europe Active Pharmaceutical Ingredients Market Overview
- 15.2. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Active Pharmaceutical Ingredients Market
- 16.1. UK Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Active Pharmaceutical Ingredients Market
- 17.1. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Active Pharmaceutical Ingredients Market
- 18.1. France Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Active Pharmaceutical Ingredients Market
- 19.1. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Active Pharmaceutical Ingredients Market
- 20.1. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Active Pharmaceutical Ingredients Market
- 21.1. Eastern Europe Active Pharmaceutical Ingredients Market Overview
- 21.2. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Active Pharmaceutical Ingredients Market
- 22.1. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Active Pharmaceutical Ingredients Market
- 23.1. North America Active Pharmaceutical Ingredients Market Overview
- 23.2. North America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Active Pharmaceutical Ingredients Market
- 24.1. USA Active Pharmaceutical Ingredients Market Overview
- 24.2. USA Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Active Pharmaceutical Ingredients Market
- 25.1. Canada Active Pharmaceutical Ingredients Market Overview
- 25.2. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Active Pharmaceutical Ingredients Market
- 26.1. South America Active Pharmaceutical Ingredients Market Overview
- 26.2. South America Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Active Pharmaceutical Ingredients Market
- 27.1. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Active Pharmaceutical Ingredients Market
- 28.1. Middle East Active Pharmaceutical Ingredients Market Overview
- 28.2. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Active Pharmaceutical Ingredients Market
- 29.1. Africa Active Pharmaceutical Ingredients Market Overview
- 29.2. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Active Pharmaceutical Ingredients Market, Segmentation By Manufacturer, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Active Pharmaceutical Ingredients Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Active Pharmaceutical Ingredients Market Competitive Landscape And Company Profiles
- 30.1. Active Pharmaceutical Ingredients Market Competitive Landscape
- 30.2. Active Pharmaceutical Ingredients Market Company Profiles
- 30.2.1. Albemarle Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Aurobindo Pharma Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Dr. Reddy's Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Teva Pharmaceutical Industries Limited Overview, Products and Services, Strategy and Financial Analysis
31. Active Pharmaceutical Ingredients Market Other Major And Innovative Companies
- 31.1. Cipla Limited
- 31.2. Boehringer Ingelheim International GmbH
- 31.3. Merck KGaA
- 31.4. Sun Pharmaceutical Industries Limited
- 31.5. Bristol-Myers Squibb Company
- 31.6. Mylan Pharmaceuticals ULC
- 31.7. BASF SE
- 31.8. Lupin Limited
- 31.9. Johnson & Johnson Services Inc.
- 31.10. F. Hoffmann-La Roche AG
- 31.11. Pfizer Inc.
- 31.12. Novartis International AG
- 31.13. Sanofi S.A
- 31.14. Viatris Inc.
- 31.15. Cadila Pharmaceuticals Limited
32. Global Active Pharmaceutical Ingredients Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Active Pharmaceutical Ingredients Market
34. Recent Developments In The Active Pharmaceutical Ingredients Market
35. Active Pharmaceutical Ingredients Market High Potential Countries, Segments and Strategies
- 35.1 Active Pharmaceutical Ingredients Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Active Pharmaceutical Ingredients Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Active Pharmaceutical Ingredients Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
